|
GB9127062D0
(en)
*
|
1991-12-20 |
1992-02-19 |
Unilever Plc |
Lip treatment composition
|
|
WO1994013257A1
(en)
*
|
1992-12-16 |
1994-06-23 |
Creative Products Resource Associates, Ltd. |
Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
|
|
JP3566739B2
(ja)
*
|
1993-09-30 |
2004-09-15 |
三省製薬株式会社 |
皮膚外用剤の安定化方法
|
|
DE69535758D1
(de)
*
|
1994-08-29 |
2008-07-03 |
Univ Wake Forest |
Lipid-analoge zur behandlung von viralen infektionen
|
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
US5614489A
(en)
*
|
1995-05-25 |
1997-03-25 |
Mohammadi; Fatemeh |
Method and composition for treating the skin
|
|
FR2736827B1
(fr)
*
|
1995-07-21 |
1997-09-19 |
Boucher Christine Bernard |
Huile cosmetique extraite des plantes du genre calophyllum
|
|
FR2737118B1
(fr)
*
|
1995-07-28 |
1997-09-05 |
Oreal |
Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
|
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
|
DE19720083A1
(de)
*
|
1997-05-14 |
1998-11-19 |
Silvia Zender |
Arzneimittel
|
|
IL134590A0
(en)
*
|
1997-09-08 |
2001-04-30 |
Univ Georgetown |
Substituted 2-pyrrolidinone activators of pkc
|
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
|
US6156745A
(en)
*
|
1997-12-29 |
2000-12-05 |
Research Corporation Technologies, Inc. |
2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors
|
|
US6432941B1
(en)
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
|
US6051603A
(en)
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
|
DE19825856A1
(de)
*
|
1998-06-10 |
1999-12-16 |
Labtec Gmbh |
Topische Arzneimittelzubereitung
|
|
US6355678B1
(en)
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
|
AUPP583198A0
(en)
*
|
1998-09-11 |
1998-10-01 |
Soltec Research Pty Ltd |
Mousse composition
|
|
US8263580B2
(en)
*
|
1998-09-11 |
2012-09-11 |
Stiefel Research Australia Pty Ltd |
Vitamin formulation
|
|
JP3211027B2
(ja)
*
|
1998-11-13 |
2001-09-25 |
丸石製薬株式会社 |
カプサイシン含有外用剤
|
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
AU759875B2
(en)
|
1999-03-09 |
2003-05-01 |
Pharmacia & Upjohn Company |
4-OXO-4,7-dihydro-thieno(2,3-b)pyridine-5-carboxamides as antiviral agents
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US6258820B1
(en)
*
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
|
WO2000069470A2
(en)
*
|
1999-05-17 |
2000-11-23 |
Aesgen, Inc. |
Improved cellular uptake of bioactive agents
|
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
|
WO2000078793A2
(en)
*
|
1999-06-22 |
2000-12-28 |
University Of Louisville Research Foundation, Inc. |
Antimicrobial agents
|
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
WO2001036431A1
(en)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
|
US6967023B1
(en)
*
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
|
IL133968A0
(en)
*
|
2000-01-10 |
2001-04-30 |
Thixo Ltd |
Therapeutic oils and edible pastes containing the same
|
|
BR0109391A
(pt)
|
2000-03-21 |
2003-06-03 |
Upjohn Co |
4-hidroxicinolina-3-carboxiamidas como agentes antivirais
|
|
WO2001070742A1
(en)
|
2000-03-21 |
2001-09-27 |
Pharmacia & Upjohn Company |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
|
JP2003529601A
(ja)
|
2000-03-21 |
2003-10-07 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての４−オキソ−１，４−ジヒドロ［１，８］ナフチリジン−３−カルボキサミド
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
US6682892B2
(en)
*
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
|
WO2002026761A1
(en)
|
2000-09-29 |
2002-04-04 |
Regents Of The University Of Minnesota |
Triterpenes having fungicidal activity against yeast
|
|
US6689767B2
(en)
*
|
2000-09-29 |
2004-02-10 |
Regents Of The University Of Minnesota |
Triterpenes having antibacterial activity
|
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
|
US6958359B1
(en)
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
WO2002060936A2
(en)
*
|
2001-01-31 |
2002-08-08 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
CN1486289A
(zh)
*
|
2001-05-29 |
2004-03-31 |
皇家菲利浦电子有限公司 |
金属-陶瓷的结合
|
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
US6916801B2
(en)
*
|
2001-07-24 |
2005-07-12 |
Alamx, Llc |
7-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitors
|
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
|
IL160080A0
(en)
*
|
2001-08-31 |
2004-06-20 |
Thomson Licensing Sa |
Sequence counter for an audio visual stream
|
|
US20040157280A1
(en)
*
|
2001-09-17 |
2004-08-12 |
Paul Wentworth |
Antibody mediated ozone generation
|
|
US20040116350A1
(en)
*
|
2001-09-17 |
2004-06-17 |
Paul Wentworth Jr |
Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
|
|
US20050129680A1
(en)
*
|
2001-09-17 |
2005-06-16 |
Paul Wentworth |
Antimicrobial activity of antibodies
|
|
WO2003029264A2
(en)
*
|
2001-10-01 |
2003-04-10 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
|
|
US20030143199A1
(en)
*
|
2001-10-09 |
2003-07-31 |
Carson Dennis A. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
WO2003041660A2
(en)
|
2001-11-14 |
2003-05-22 |
Rutgers, The State University |
Solubilized topoisomerase poisons
|
|
CN1684582A
(zh)
|
2001-11-23 |
2005-10-19 |
拉特格斯州立大学 |
聚酐类的改进合成法
|
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
JP2005530685A
(ja)
*
|
2002-01-25 |
2005-10-13 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
選択的鎮痛剤
|
|
JP2005525399A
(ja)
*
|
2002-04-04 |
2005-08-25 |
アラムクス エルエルシー |
セリンおよびメタロ−β−ラクタマーゼの阻害剤
|
|
AUPS158502A0
(en)
*
|
2002-04-08 |
2002-05-16 |
Dermcare-Vet Pty Ltd |
Allergic dermatitis composition and method of treatment
|
|
ATE381336T1
(de)
*
|
2002-04-10 |
2008-01-15 |
Univ Virginia |
Verwendung von a2a adenosin rezeptor agonisten und anti-pathogene mittel enthaltenden kombinationen zur behandlung von entzündungskrankheiten
|
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
|
CN1802152A
(zh)
*
|
2002-08-01 |
2006-07-12 |
艾斯根公司 |
用谷氨酰胺改善癌症的治疗
|
|
WO2004014918A1
(en)
*
|
2002-08-09 |
2004-02-19 |
Rutgers, The State University |
Nitro and amino substituted topoisomerase agents
|
|
US7438918B2
(en)
*
|
2002-08-30 |
2008-10-21 |
University Of Iowa Research Foundation |
Lipid A deficient mutants of Neisseria meningitidis
|
|
CA2497003A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Warner-Lambert Company Llc |
Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
|
|
WO2004032599A2
(en)
|
2002-10-10 |
2004-04-22 |
Cornell Research Foundation, Inc. |
Novel immunogenic proteins of leptospira
|
|
EP1552025A4
(en)
*
|
2002-10-18 |
2006-12-13 |
Cylene Pharmaceuticals Inc |
METHODS FOR IDENTIFYING TARGETED ANTIVIRAL MOLECULES TO QUADRUPLEX STRUCTURES
|
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US20050205086A1
(en)
*
|
2002-10-25 |
2005-09-22 |
Foamix Ltd. |
Retinoid immunomodulating kit and composition and uses thereof
|
|
US7704518B2
(en)
*
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US10117812B2
(en)
*
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US8486376B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US20060018937A1
(en)
*
|
2002-10-25 |
2006-01-26 |
Foamix Ltd. |
Steroid kit and foamable composition and uses thereof
|
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
|
US20070292355A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Anti-infection augmentation foamable compositions and kit and uses thereof
|
|
US20070292359A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
US20050271596A1
(en)
*
|
2002-10-25 |
2005-12-08 |
Foamix Ltd. |
Vasoactive kit and composition and uses thereof
|
|
US8119109B2
(en)
*
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
US20080317679A1
(en)
*
|
2002-10-25 |
2008-12-25 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
|
US20060193789A1
(en)
*
|
2002-10-25 |
2006-08-31 |
Foamix Ltd. |
Film forming foamable composition
|
|
MXPA05004278A
(es)
*
|
2002-10-25 |
2005-10-05 |
Foamix Ltd |
Espuma cosmetica y farmaceutica.
|
|
US7544674B2
(en)
|
2002-10-25 |
2009-06-09 |
Galderma S.A. |
Topical skin care composition
|
|
US20080206161A1
(en)
*
|
2002-10-25 |
2008-08-28 |
Dov Tamarkin |
Quiescent foamable compositions, steroids, kits and uses thereof
|
|
US20050186142A1
(en)
*
|
2002-10-25 |
2005-08-25 |
Foamix Ltd. |
Kit and composition of imidazole with enhanced bioavailability
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US9265725B2
(en)
*
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
AU2003286004A1
(en)
|
2002-11-08 |
2004-06-07 |
Ablynx N.V. |
Single domain antibodies directed against interferon- gamma and uses therefor
|
|
JP2006520584A
(ja)
|
2002-11-08 |
2006-09-14 |
アブリンクス エン．ヴェー． |
安定化単一ドメイン抗体
|
|
CN100570365C
(zh)
*
|
2002-11-14 |
2009-12-16 |
斯克里普斯研究所 |
抗体或嗜中性粒细胞介导的臭氧产生
|
|
WO2004062583A2
(en)
*
|
2003-01-07 |
2004-07-29 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
|
CN101412759A
(zh)
|
2003-01-10 |
2009-04-22 |
埃博灵克斯股份有限公司 |
治疗性多肽,其同源物、其片段及其在调节血小板介导的聚集方面的应用
|
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
|
EP1610795A4
(en)
*
|
2003-04-07 |
2007-10-24 |
Cylene Pharmaceuticals Inc |
SUBSTITUTED 1,4-DIHYDRO-4-OXO-1,8-NAPHTHPYRIDINE HETEROCYCLIC ANALOGUES
|
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
|
JP2006522827A
(ja)
*
|
2003-04-07 |
2006-10-05 |
サイリーン ファーマシューティカルズ インコーポレーティッド |
置換キノベンゾオキサジン類似体
|
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
PT1653943E
(pt)
|
2003-06-25 |
2008-05-23 |
Burnham Inst |
Derivados de catecol para o tratamento do cancro
|
|
WO2005003140A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
|
WO2005009406A1
(en)
*
|
2003-07-18 |
2005-02-03 |
Hill Dermaceuticals, Inc. |
Topical skin care composition containing refined peanut oil
|
|
US20070140999A1
(en)
*
|
2003-07-18 |
2007-06-21 |
Hill Dermaceuticals, Inc. |
Topical skin care composition containing refined peanut oil
|
|
US8486374B2
(en)
*
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
CN1894250B
(zh)
|
2003-08-25 |
2010-06-09 |
PGx健康有限责任公司 |
取代的8-杂芳基黄嘌呤
|
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
|
US20060099173A1
(en)
*
|
2003-10-24 |
2006-05-11 |
Nancy Puglia |
Topical skin care composition
|
|
ES2352697T3
(es)
|
2003-11-07 |
2011-02-22 |
Ablynx N.V. |
Anticuerpos de dominio único de camelidae vhh dirigidos contra el receptor del factor de crecimiento epidérmico y usos de los mismos.
|
|
CA2550447A1
(en)
*
|
2003-12-19 |
2005-07-07 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies
|
|
CA2555121A1
(en)
*
|
2004-02-04 |
2005-08-25 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam with solid matter
|
|
US20060003948A1
(en)
*
|
2004-02-06 |
2006-01-05 |
Krasutsky Pavel A |
Compositions that include a triterpene and a carrier
|
|
EP1720841B1
(en)
|
2004-02-19 |
2015-11-04 |
Rexahn Pharmaceuticals, Inc. |
Quinazoline derivatives and therapeutic use thereof
|
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
|
AU2005232526B2
(en)
*
|
2004-02-24 |
2011-06-23 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
|
PL2574341T3
(pl)
|
2004-03-29 |
2017-09-29 |
University Of South Florida |
Efektywne leczenie guzów i raka fosforanem tricyrybiny
|
|
WO2006028618A1
(en)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
|
EP1778712B1
(en)
|
2004-08-02 |
2013-01-30 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
|
EP1793832B1
(en)
*
|
2004-08-25 |
2014-07-23 |
University of Iowa Research |
Geranylgeranyl pyrophosphate synthase inhibitors
|
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
|
CA2583017A1
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease
|
|
US8697674B2
(en)
*
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
|
WO2006086103A2
(en)
*
|
2005-01-10 |
2006-08-17 |
University Of Virginia Patent Foundation |
Synthesis of inhibitors of p90rsk
|
|
CA2610662A1
(en)
*
|
2005-05-09 |
2007-05-18 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
EP1893196B2
(en)
|
2005-05-13 |
2015-07-29 |
The Regents of The University of California |
Diarylhydantoin compound
|
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
EP2172484A3
(en)
|
2005-05-18 |
2010-05-19 |
Ablynx N.V. |
Serum albumin binding proteins
|
|
CN101213214B
(zh)
|
2005-05-20 |
2014-06-25 |
埃博灵克斯股份有限公司 |
针对冯威勒布兰特因子的单一结构域vhh抗体
|
|
ES2407407T3
(es)
|
2005-06-01 |
2013-06-12 |
Glaxosmithkline Intellectual Property Development Limited |
Formulación de vitamina
|
|
US20080152596A1
(en)
*
|
2005-07-19 |
2008-06-26 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
EP1909783B1
(en)
*
|
2005-08-03 |
2011-10-12 |
The Regents of the University of California |
Illudin analogs useful as anticancer agents
|
|
ES2577514T3
(es)
|
2005-08-22 |
2016-07-15 |
The Regents Of The University Of California |
Antagonistas de TLR
|
|
US20070098667A1
(en)
*
|
2005-10-27 |
2007-05-03 |
Jim Taneri |
Methods and compositions for epilation
|
|
US20070098660A1
(en)
*
|
2005-10-27 |
2007-05-03 |
Jim Taneri |
Methods and compositions for epilation
|
|
WO2007056113A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Cylene Pharmaceuticals, Inc. |
Methods for targeting quadruplex sequences
|
|
US8178509B2
(en)
*
|
2006-02-10 |
2012-05-15 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
|
AU2007217366A1
(en)
|
2006-02-27 |
2007-08-30 |
The Regents Of The University Of California |
Oxysterol compounds and the hedgehog pathway
|
|
AU2007229457A1
(en)
*
|
2006-03-22 |
2007-10-04 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
|
SI2368550T1
(sl)
|
2006-03-27 |
2013-11-29 |
The Regents Of The University Of California |
Modulator androgenskih receptorjev za zdravljenje raka prostate in bolezni, povezanih z androgenskimi receptorji
|
|
MX2008012492A
(es)
|
2006-03-29 |
2008-12-12 |
Univ California |
Compuestos de diariltiohidantoina.
|
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
|
WO2007139778A2
(en)
*
|
2006-05-22 |
2007-12-06 |
University Of Virginia Patent Foundation |
Rhamnose substituents of sl0101 and therapeutic uses thereof
|
|
US20110112086A1
(en)
*
|
2006-06-08 |
2011-05-12 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs
|
|
WO2007146831A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
|
MX2009002536A
(es)
*
|
2006-09-08 |
2009-04-14 |
Foamix Ltd |
Composicion espumable coloreada o coloreable y espuma.
|
|
US20080206155A1
(en)
*
|
2006-11-14 |
2008-08-28 |
Foamix Ltd. |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
|
US20080260655A1
(en)
*
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
|
CA2670595A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
(r)-5-methyl-4,5-dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chlorophenyl)amide 5-{[2-fluoro-4-(2-oxo-2h-pyridin-1-yl)-phenyl)amide) as a fact or xa inhibitor
|
|
US20100062004A1
(en)
|
2006-12-19 |
2010-03-11 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
EP2514767A1
(en)
|
2006-12-19 |
2012-10-24 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
EP2111385B1
(en)
|
2007-02-06 |
2014-11-12 |
University Of Louisville Research Foundation, Inc. |
Substituted alkine derivatives as anti-cancer agents
|
|
SI2510946T1
(sl)
|
2007-02-07 |
2015-12-31 |
The Regents Of The University Of California |
Konjugati sintetičnih agonistov TLR in njihove uporabe
|
|
US20100143270A1
(en)
*
|
2007-02-21 |
2010-06-10 |
University Of Louisville Research Foubdation |
Therapeutic cotinine compositions
|
|
WO2008138001A2
(en)
|
2007-05-08 |
2008-11-13 |
University Of Louisville Research Foundation |
Synthetic peptides and peptide mimetics
|
|
CN101743007B
(zh)
|
2007-07-12 |
2015-04-08 |
南佛罗里达大学 |
具有抗肿瘤活性的akt/pkb抑制剂
|
|
MX2010001303A
(es)
|
2007-08-02 |
2010-09-07 |
Univ Rutgers |
Compuestos terapeuticos.
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
ES2582662T3
(es)
*
|
2007-10-05 |
2016-09-14 |
Senhwa Biosciences, Inc. |
Análogos de quinolona y procedimientos relacionados con los mismos
|
|
US9115061B2
(en)
*
|
2007-10-19 |
2015-08-25 |
Burnham Institute For Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
|
WO2009055677A1
(en)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Antibacterial s-heterosubstituted disulfides
|
|
JP5535925B2
(ja)
|
2007-10-26 |
2014-07-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物
|
|
US20090130029A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Foamix Ltd. |
Glycerol ethers vehicle and pharmaceutical compositions thereof
|
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
|
US9526737B2
(en)
|
2007-12-03 |
2016-12-27 |
The Regents Of The University Of California |
Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling
|
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
CA2712120A1
(en)
*
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
US8142764B2
(en)
|
2008-02-27 |
2012-03-27 |
University Of Louisville Research Foundation |
Synthetic biofilm-inhibiting peptides
|
|
WO2009114539A2
(en)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
|
|
WO2009114921A1
(en)
*
|
2008-03-17 |
2009-09-24 |
Dmitrienko Gary I |
INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES
|
|
WO2009146112A1
(en)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions and methods for inhibiting sphingosine kinase
|
|
US8557965B2
(en)
|
2008-04-07 |
2013-10-15 |
Ablynx N.V. |
Single variable domains against notch pathway members
|
|
RU2527561C2
(ru)
|
2008-04-16 |
2014-09-10 |
Говард Юнивесити |
Ингибиторы протеинфосфатазы-1 и их применение
|
|
EP2285833B1
(en)
|
2008-05-16 |
2014-12-17 |
Ablynx N.V. |
AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
|
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
|
WO2010005534A2
(en)
*
|
2008-06-30 |
2010-01-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
US20090324506A1
(en)
*
|
2008-06-30 |
2009-12-31 |
Jeffery Richard Seidling |
Sprayable skin protectant formulation and method of use
|
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
|
WO2010011666A2
(en)
*
|
2008-07-21 |
2010-01-28 |
University Of South Florida |
Indoline scaffold shp-2 inhibitors and cancer treatment method
|
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
|
WO2010014054A1
(en)
*
|
2008-07-28 |
2010-02-04 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
|
WO2010017224A2
(en)
*
|
2008-08-05 |
2010-02-11 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
WO2010017550A2
(en)
*
|
2008-08-08 |
2010-02-11 |
University Of Florida Research Foundation, Inc. |
Lipid compounds for supression of tumorigenesis
|
|
US9480691B1
(en)
*
|
2009-01-20 |
2016-11-01 |
Hill Dermaceuticals, Inc. |
Topical liquid containing refined peanut oil for treating skin proliferation or inflammation disorders
|
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
|
US20100240612A1
(en)
|
2009-03-20 |
2010-09-23 |
University Of Iowa Research Foundation |
Prenylated Bisphosphonates as Anti-tuberculosis Agents
|
|
BRPI1013877A2
(pt)
|
2009-04-10 |
2017-08-15 |
Ablynx Nv |
Sequências de aminoácidos melhoradas contra il-6r e polipeptídeos que compreendem os mesmos para o tratamento de doenças e distúrbios relacionados com il-6r
|
|
EP2418942B1
(en)
|
2009-04-15 |
2017-08-23 |
Sanford-Burnham Medical Research Institute |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
|
US20120087872A1
(en)
|
2009-04-28 |
2012-04-12 |
Foamix Ltd. |
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
|
|
US8748618B2
(en)
|
2009-05-13 |
2014-06-10 |
University Of Virginia Patent Foundation |
Inhibitors of inv(16) leukemia
|
|
US8263762B2
(en)
|
2009-06-30 |
2012-09-11 |
Dogwood Pharmaceuticals, Inc. |
Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists
|
|
WO2011005871A1
(en)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists
|
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
AU2010278730A1
(en)
|
2009-07-31 |
2012-03-01 |
Biocryst Pharmaceuticals, Inc. |
Pyrrolo [1, 2-b] pyridazine derivatives as janus kinase inhibitors
|
|
US9040673B2
(en)
|
2009-08-14 |
2015-05-26 |
University Of Virginia Patent Foundation |
Synthesis and identification of novel RSK-specific inhibitors
|
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
BR112012007473A2
(pt)
|
2009-10-02 |
2019-05-07 |
Foamix Ltd |
composições tópicas de tetraciclina e respectivo método de uso
|
|
MX2012004064A
(es)
*
|
2009-10-08 |
2012-06-08 |
Sanford Burnham Med Res Inst |
Derivados apogosipolona como agentes antineoplasicos.
|
|
WO2011057126A1
(en)
|
2009-11-05 |
2011-05-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
CN102892755A
(zh)
|
2009-12-23 |
2013-01-23 |
韦恩州立大学 |
治疗性化合物
|
|
TW201132644A
(en)
|
2009-12-23 |
2011-10-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as Janus kinase inhibitors
|
|
DK3124481T3
(en)
|
2010-02-16 |
2018-05-07 |
Aragon Pharmaceuticals Inc |
ANDROGEN RECEPTOR MODULATORS AND APPLICATIONS THEREOF
|
|
US20120329770A1
(en)
|
2010-02-26 |
2012-12-27 |
Gary Igor Dmitrienko |
Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
|
|
JP2013523777A
(ja)
|
2010-04-02 |
2013-06-17 |
ティーエスアールエル インコーポレイテッド |
ノイラミニダーゼ阻害剤
|
|
WO2011130740A2
(en)
|
2010-04-16 |
2011-10-20 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
|
|
WO2011133696A2
(en)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Methods of suppressing atherosclerosis
|
|
AR081428A1
(es)
|
2010-05-28 |
2012-08-29 |
Biocryst Pharm Inc |
Derivados heterociclicos condensados nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos para suprimir una respuesta inmune o tratar cancer.
|
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
|
US8609672B2
(en)
|
2010-08-27 |
2013-12-17 |
University Of The Pacific |
Piperazinylpyrimidine analogues as protein kinase inhibitors
|
|
CN103384511A
(zh)
|
2010-09-20 |
2013-11-06 |
欧莱雅 |
包含烷基纤维素的含水美容化合物
|
|
WO2012038374A2
(en)
|
2010-09-20 |
2012-03-29 |
L'oreal |
Aqueous cosmetic composition comprising alkylcellulose
|
|
EP2632481A1
(en)
|
2010-10-25 |
2013-09-04 |
Regents Of The University Of Minnesota |
Therapeutic composition for treatment of glioblastoma
|
|
EA026745B8
(ru)
|
2011-02-07 |
2022-01-31 |
Байоджен Ма Инк. |
Модуляторы s1p
|
|
AU2012225574A1
(en)
|
2011-03-07 |
2013-09-26 |
University Of Louisville Research Foundation, Inc. |
Predictive marker of DNMT1 inhibitor therapeutic efficacy and methods of using the marker
|
|
US9616064B2
(en)
|
2011-03-30 |
2017-04-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Rho kinase inhibitors and methods of use
|
|
MX356426B
(es)
|
2011-04-04 |
2018-05-29 |
Univ Iowa Res Found |
Metodos para mejorar inmunogenicidad de vacuna.
|
|
WO2012139015A1
(en)
|
2011-04-06 |
2012-10-11 |
Rutgers, The State University Of New Jersey |
Polymers and methods for the treatment of pain
|
|
US20120270860A1
(en)
|
2011-04-19 |
2012-10-25 |
Gihyun Yoon |
Methods for treating or preventing alcohol-related disorders or craving-related disorders
|
|
WO2012145678A1
(en)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Anti-cancer and anti-inflammatory parthenolide compounds
|
|
US9415112B2
(en)
|
2011-06-20 |
2016-08-16 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial RNA polymerase
|
|
US9394338B2
(en)
|
2011-07-08 |
2016-07-19 |
Regents Of The University Of Minnesota |
Glutathione analogs and uses thereof
|
|
AU2012287103B2
(en)
|
2011-07-22 |
2017-03-30 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
|
CA2843417C
(en)
|
2011-07-29 |
2018-08-21 |
Medivation Prostate Therapeutics, Inc. |
Treatment of breast cancer
|
|
WO2013028866A1
(en)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
EP2750508A4
(en)
|
2011-08-30 |
2015-01-14 |
Univ Wayne State |
COMPOUNDS AND THERAPEUTIC METHODS
|
|
WO2013033345A1
(en)
|
2011-08-30 |
2013-03-07 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
CN103781471B
(zh)
|
2011-09-08 |
2019-02-12 |
健康科学西部大学 |
癌症治疗中的靶向脂质体
|
|
AU2012308582B2
(en)
|
2011-09-15 |
2016-11-24 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Therapeutic compounds
|
|
WO2013101719A2
(en)
*
|
2011-12-27 |
2013-07-04 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
|
FR2985176B1
(fr)
|
2012-01-02 |
2015-05-29 |
Oreal |
Composition cosmetique liquide aqueuse comprenant de l'alkylcellulose, des huiles non volatiles et au moins un tensioactif
|
|
WO2013103969A1
(en)
|
2012-01-05 |
2013-07-11 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
|
WO2013106572A1
(en)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
US8947424B2
(en)
|
2012-01-17 |
2015-02-03 |
Eastman Kodak Company |
Spectral stereoscopic projection system
|
|
US9333242B2
(en)
|
2012-01-19 |
2016-05-10 |
Hybrid Medical, Llc |
Topical therapeutic formulations
|
|
EP2804852A2
(en)
|
2012-01-20 |
2014-11-26 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
WO2013113102A1
(en)
|
2012-02-01 |
2013-08-08 |
The Governors Of The University Of Alberta |
USE OF PDGFR-α AS DIAGNOSTIC MARKER FOR PAPILLARY THYROID CANCER
|
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
|
US9839634B2
(en)
|
2012-02-06 |
2017-12-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
|
US9688668B2
(en)
|
2012-02-08 |
2017-06-27 |
University Of Virginia Patent Foundation |
Long chain base sphingosine kinase inhibitors
|
|
US9187446B2
(en)
|
2012-03-22 |
2015-11-17 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechainfluorinated myxopyronin derivatives
|
|
AU2013240007B2
(en)
|
2012-03-26 |
2017-06-29 |
University Of Iowa Research Foundation |
Schweinfurthin analogues
|
|
US9340501B2
(en)
|
2012-04-16 |
2016-05-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Marinopyrrole derivatives as anticancer agents
|
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
|
WO2013169399A1
(en)
|
2012-05-07 |
2013-11-14 |
The Regents Of The University Of California |
Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
|
|
ES2689541T3
(es)
|
2012-06-19 |
2018-11-14 |
Rutgers, The State University Of New Jersey |
Agentes antibacterianos: derivados de aril mixopironina
|
|
ES2784223T3
(es)
|
2012-06-20 |
2020-09-23 |
Univ Virginia Patent Foundation |
Composiciones y procedimientos para regular la homeostasis de glucosa y la acción de insulina
|
|
US9669115B2
(en)
|
2012-06-29 |
2017-06-06 |
University Of Iowa Research Foundation |
Co-crystals and salts of contrast agents and imaging
|
|
CA2878413A1
(en)
|
2012-07-05 |
2014-01-09 |
University Of Iowa Research Foundation |
Therapeutic bisphosphonates
|
|
CN104718213B
(zh)
|
2012-07-18 |
2018-02-27 |
圣母大学 |
5,5‑杂芳族抗感染化合物
|
|
WO2014018671A1
(en)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds for the treatment of cancer
|
|
CN104768541B
(zh)
|
2012-07-27 |
2018-08-17 |
比奥根艾迪克Ma公司 |
Atx调节剂
|
|
EP2879683B1
(en)
|
2012-08-01 |
2020-01-22 |
Lewis and Clark Pharmaceuticals, Inc. |
N-alkyl-alkynyladenosine-5-uronamide compounds as agonists of a2a receptor
|
|
JP6265558B2
(ja)
|
2012-08-03 |
2018-01-24 |
ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ |
酵素活性化化合物及び組成物
|
|
US10273234B2
(en)
|
2012-08-06 |
2019-04-30 |
Biogen Ma Inc. |
Compounds that are S1P modulating agents and/or ATX modulating agents
|
|
US9499485B2
(en)
|
2012-08-06 |
2016-11-22 |
Biogen Ma Inc. |
Compounds that are S1P modulating agents and/or ATX modulating agents
|
|
WO2014031732A2
(en)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methods for inhibiting fascin
|
|
US9737493B2
(en)
|
2012-09-07 |
2017-08-22 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating DNMT1 inhibitor activity
|
|
WO2014043252A2
(en)
|
2012-09-11 |
2014-03-20 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
|
IL312316A
(en)
|
2012-09-26 |
2024-06-01 |
Aragon Pharmaceuticals Inc |
Antiandrogens for the treatment of castration-resistant prostate cancer without metastases
|
|
CA2887913A1
(en)
|
2012-10-10 |
2014-04-17 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Multifunctional radical quenchers
|
|
WO2014059350A1
(en)
|
2012-10-12 |
2014-04-17 |
Regents Of The University Of Minnesota |
Open chained or fused 1,1 '-alkylene-bis-uracil derivatives, useful in skin uv-protection
|
|
US9296730B2
(en)
|
2012-10-26 |
2016-03-29 |
Regents Of The University Of Minnesota |
Aurora kinase inhibitors
|
|
US10519161B2
(en)
|
2012-10-29 |
2019-12-31 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
|
WO2014074926A1
(en)
|
2012-11-09 |
2014-05-15 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
|
JP2016504284A
(ja)
|
2012-11-16 |
2016-02-12 |
バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
抗ウイルス性アザ糖を含有するヌクレオシド
|
|
US9670199B2
(en)
|
2012-11-19 |
2017-06-06 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
|
ES2636596T3
(es)
|
2012-11-20 |
2017-10-06 |
Biogen Ma Inc. |
Agentes moduladores de S1P y/o ATX
|
|
US9771326B2
(en)
|
2012-11-20 |
2017-09-26 |
Biogen Ma Inc. |
S1P and/or ATX modulating agents
|
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
|
US9700044B2
(en)
|
2013-01-22 |
2017-07-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Symmetrical marinopyrrole derivatives as potential antibiotic agents
|
|
WO2014120764A1
(en)
|
2013-01-29 |
2014-08-07 |
Biogen Idec Ma Inc. |
S1p modulating agents
|
|
WO2014124317A1
(en)
|
2013-02-08 |
2014-08-14 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
|
US9776975B2
(en)
|
2013-03-05 |
2017-10-03 |
University Of Notre Dame Du Lac |
Quinazolinone antibiotics
|
|
RU2015144185A
(ru)
|
2013-03-15 |
2017-04-26 |
Дженентек, Инк. |
Лечение заболеваний, опосредованных тh2, путем ингибирования бромодоменов
|
|
US20160039825A1
(en)
|
2013-03-15 |
2016-02-11 |
Biogen Ma Inc. |
S1p and/or atx modulating agents
|
|
EP2970334B1
(en)
|
2013-03-15 |
2018-05-23 |
Biogen MA Inc. |
Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
|
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
|
US9683009B2
(en)
|
2013-05-02 |
2017-06-20 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol-bone targeting agents
|
|
WO2014194055A1
(en)
|
2013-05-29 |
2014-12-04 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
|
US9987211B2
(en)
|
2013-07-03 |
2018-06-05 |
Regents Of The University Of Minnesota |
Sunless tanning compounds and compositions
|
|
CN105592850B
(zh)
|
2013-08-06 |
2019-11-15 |
H·李·莫菲特癌症中心研究所公司 |
Ack1/tnk2酪氨酸激酶的抑制剂
|
|
CN112353791A
(zh)
|
2013-11-11 |
2021-02-12 |
夸利蒂赫布丘蒂克斯公司 |
卡瓦衍生的治疗性化合物及其使用方法
|
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
|
WO2015120320A1
(en)
|
2014-02-06 |
2015-08-13 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides
|
|
EP3107902B1
(en)
|
2014-02-20 |
2021-04-07 |
Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") |
Compounds and methods for inhibiting fascin
|
|
WO2015130805A1
(en)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dna gridiron compositions and methods
|
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
MX2016011468A
(es)
|
2014-03-07 |
2017-01-23 |
Biocryst Pharm Inc |
Inhibidores de calicreína plasmática humana.
|
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
|
US10266603B2
(en)
|
2014-04-18 |
2019-04-23 |
The Governors Of The University Of Alberta |
Targeted therapy to restore radioactive iodine transport in thyroid cancer
|
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
|
WO2015168636A1
(en)
|
2014-05-02 |
2015-11-05 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol bisphosphonate analogs
|
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
|
EP3152206A1
(en)
|
2014-06-06 |
2017-04-12 |
Biogen MA Inc. |
Atx modulating agents
|
|
WO2015195563A1
(en)
|
2014-06-16 |
2015-12-23 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
|
KR102299276B1
(ko)
*
|
2014-07-16 |
2021-09-09 |
(주)아모레퍼시픽 |
납떼기콩 오일을 포함하는 조성물
|
|
IL250405B
(en)
|
2014-08-19 |
2022-08-01 |
Miller Marvin J |
Antibacterial sideromycins
|
|
CA2964239C
(en)
|
2014-09-11 |
2022-12-13 |
University Of Iowa Research Foundation |
Thymol and carvacol for use in medicine
|
|
US10920195B2
(en)
|
2014-11-13 |
2021-02-16 |
University Of Iowa Research Foundation |
Methods to generate epithelial cells
|
|
JP6770534B2
(ja)
|
2015-02-17 |
2020-10-21 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
治療用化合物
|
|
CA2976776C
(en)
|
2015-02-17 |
2023-06-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Phenothiazine analogues as mitochondrial therapeutic agents
|
|
WO2016172187A1
(en)
|
2015-04-20 |
2016-10-27 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods and compositions related to kras inhibitors
|
|
US20180126013A1
(en)
|
2015-05-06 |
2018-05-10 |
H.Lee Moffitt Cancer Center And Research Institute, Inc. |
Radiotherapeutic and companion imaging agents to target mc1r
|
|
CN108026084A
(zh)
|
2015-05-07 |
2018-05-11 |
夸利蒂赫布丘蒂克斯公司 |
治疗化合物及其使用方法
|
|
US10188704B2
(en)
|
2015-05-18 |
2019-01-29 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Enhanced melanoma cancer prevention by novel melanotropins
|
|
WO2016205397A2
(en)
|
2015-06-15 |
2016-12-22 |
Klibanov Alexander L |
Target-specific delivery of therapeutic agents
|
|
WO2016205534A1
(en)
|
2015-06-16 |
2016-12-22 |
Lazo John S |
Inhibitors of ptp4a3 for the treatment of cancer
|
|
WO2017011686A1
(en)
|
2015-07-14 |
2017-01-19 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
|
US10729669B2
(en)
|
2015-07-28 |
2020-08-04 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
|
WO2017023899A1
(en)
|
2015-08-02 |
2017-02-09 |
H. Lee Moffitt Cancer Center & Research Institute |
Inhibitors of ack1/tnk2 tyrosine kinase
|
|
US10550124B2
(en)
|
2015-08-13 |
2020-02-04 |
San Diego State University Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
|
JP6736661B2
(ja)
|
2015-09-04 |
2020-08-05 |
ヤンセン ファーマシューティカ エヌ．ベー． |
治療化合物及び合成
|
|
AU2016332847B2
(en)
|
2015-10-01 |
2023-08-10 |
Goleini Inc. |
Targeted expression of chloride channels and methods of use thereof
|
|
MY198346A
(en)
|
2015-10-01 |
2023-08-28 |
Biocryst Pharm Inc |
Human plasma kallikrein inhibitors
|
|
WO2017066428A1
(en)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Brd4-kinase inhibitors as cancer therapeutics
|
|
CA3004048A1
(en)
|
2015-11-03 |
2017-05-11 |
Regents Of The University Of Minnesota |
Cd200 inhibitors and methods of use thereof
|
|
CN108601789A
(zh)
|
2015-11-20 |
2018-09-28 |
生华生物科技股份有限公司 |
用于治疗癌症的四环喹诺酮类似物组合疗法
|
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
|
JP6828040B2
(ja)
|
2015-12-21 |
2021-02-10 |
ロレアル |
アルキルセルロースと、非相溶性である炭化水素およびシリコーン油とを含む組成物ならびにそれを用いる方法
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
TWI747873B
(zh)
|
2016-02-01 |
2021-12-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
|
CN109153644B
(zh)
|
2016-03-16 |
2022-10-21 |
H·李·莫菲特癌症中心研究有限公司 |
用以增强效应t细胞功能的针对cereblon的小分子
|
|
JP2019509321A
(ja)
|
2016-03-22 |
2019-04-04 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
疼痛を処置するための組み合わせ
|
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
CN109219610A
(zh)
|
2016-04-04 |
2019-01-15 |
新泽西州立拉特格斯大学 |
拓扑异构酶毒物
|
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
|
WO2017184642A1
(en)
|
2016-04-18 |
2017-10-26 |
Morrow Kenneth Michael |
Isolation of plant extracts
|
|
JP2019514969A
(ja)
|
2016-05-04 |
2019-06-06 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
分子イメージング及びがんの免疫療法のためのδオピオイド受容体標的化薬
|
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
|
KR20190026771A
(ko)
|
2016-06-20 |
2019-03-13 |
럿거스, 더 스테이트 유니버시티 오브 뉴 저지 |
치료 화합물
|
|
AU2017281940B2
(en)
|
2016-06-24 |
2024-07-11 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
|
WO2018022802A1
(en)
|
2016-07-26 |
2018-02-01 |
University Of Southern California |
Selective bromodomain inhibition of fungal bdf1
|
|
WO2018039077A1
(en)
|
2016-08-25 |
2018-03-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
|
KR20190078587A
(ko)
|
2016-10-17 |
2019-07-04 |
제넨테크, 인크. |
치료 화합물 및 그의 사용 방법
|
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
|
AU2017348305B2
(en)
|
2016-10-31 |
2022-04-21 |
Biocryst Pharmaceuticals, Inc. |
Prodrugs of kallikrein inhibitors
|
|
EP3554285A4
(en)
|
2016-11-29 |
2021-01-20 |
University of Iowa Research Foundation |
USE OF NAD PRECURSORS TO IMPROVE MATERNAL HEALTH AND / OR DESCENDANT HEALTH
|
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
|
WO2018136792A1
(en)
|
2017-01-20 |
2018-07-26 |
The Regents Of The University Of California |
Inhibitors of the n-terminal domain of the androgen receptor
|
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
WO2018140504A1
(en)
|
2017-01-24 |
2018-08-02 |
Patel Manoj K |
Compositions and methods for blocking sodium channels
|
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
|
US10456401B2
(en)
|
2017-05-12 |
2019-10-29 |
Innovus Pharmaceuticals, Inc. |
Therapeutic methods and compositions
|
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
|
US11896591B2
(en)
|
2017-05-22 |
2024-02-13 |
University Of Virginia Patent Foundation |
Compositions and methods for preparing and using mitochondrial uncouplers
|
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
WO2018237134A1
(en)
|
2017-06-23 |
2018-12-27 |
San Diego State University Research Foundation |
ATROPISOMERISM FOR ENHANCED SELECTIVITY OF KINASE INHIBITORS
|
|
CN111479805B
(zh)
|
2017-08-29 |
2024-08-13 |
罗格斯新泽西州立大学 |
治疗性吲唑
|
|
WO2019147309A2
(en)
|
2017-08-30 |
2019-08-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Rna nanostructures and methods of making and using rna nanostructures
|
|
JP2020536891A
(ja)
|
2017-10-06 |
2020-12-17 |
ブルー セラピューティクス，インコーポレイティド |
急性又は慢性疼痛を治療する方法
|
|
KR20200070334A
(ko)
|
2017-10-16 |
2020-06-17 |
아라곤 파마슈티컬스, 인코포레이티드 |
비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐
|
|
US12037416B2
(en)
|
2017-11-17 |
2024-07-16 |
Cytogel Pharma, Llc |
Polymer agonists of mu opioid receptors
|
|
MX2020004991A
(es)
|
2017-11-17 |
2022-02-10 |
Univ Illinois |
Terapia oncológica mediante la degradación de la señalización dual de mek.
|
|
WO2019108285A1
(en)
|
2017-11-30 |
2019-06-06 |
Cytogel Pharma, Llc |
Novel analgesic pharmaceutical formulations and uses thereof
|
|
US11242533B2
(en)
|
2018-01-10 |
2022-02-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA-nanostructured double robots and methods of use thereof
|
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
|
CN112118837B
(zh)
|
2018-02-13 |
2024-07-09 |
罗格斯新泽西州立大学 |
抗菌剂：o-烷基氘化派洛宁
|
|
CA3088998A1
(en)
|
2018-02-15 |
2019-09-06 |
Senhwa Biosciences, Inc. |
Quinolone analogs and their salts, compositions, and method for their use
|
|
US11890352B2
(en)
|
2018-02-27 |
2024-02-06 |
University Of Virginia Patent Foundation |
Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer
|
|
US11572337B2
(en)
|
2018-03-06 |
2023-02-07 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: arylalkylcarboxamido phloroglucinols
|
|
TW202010742A
(zh)
|
2018-04-06 |
2020-03-16 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
|
JP2021523933A
(ja)
|
2018-04-20 |
2021-09-09 |
バージニア・テック・インテレクチュアル・プロパティーズ・インコーポレイテッドＶｉｒｇｉｎｉａ Ｔｅｃｈ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｉｅｓ， Ｉｎｃ． |
ミトコンドリア脱共役剤として有用なイミダゾピリジン
|
|
WO2020036654A2
(en)
|
2018-04-27 |
2020-02-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Highly knotted molecular topologies from single-stranded nucleic acids
|
|
CA3098492A1
(en)
|
2018-04-27 |
2019-12-19 |
University Of Iowa Research Foundation |
Compositions for chelating metals at low temperatures
|
|
US10912822B2
(en)
|
2018-06-26 |
2021-02-09 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for guided tissue regeneration
|
|
US10758594B2
(en)
|
2018-06-26 |
2020-09-01 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for treatment of skin abnormalities
|
|
BR112021000395A2
(pt)
|
2018-07-11 |
2021-04-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Compostos imunomoduladores diméricos contra mecanismos baseados em cereblon
|
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
|
WO2020028814A1
(en)
|
2018-08-03 |
2020-02-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of wee1 kinase
|
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
|
ES2906715T3
(es)
*
|
2018-09-06 |
2022-04-20 |
Marine Essence Biosciences Corp Of Usa |
Dispositivos de biomaterial para la regeneración de tejidos guiada
|
|
WO2020106454A2
(en)
|
2018-11-07 |
2020-05-28 |
Regents Of The University Of Minnesota |
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
|
|
CN113302206A
(zh)
|
2018-11-26 |
2021-08-24 |
戴纳立制药公司 |
治疗脂质代谢失调的方法
|
|
EP3911357A1
(en)
|
2019-01-14 |
2021-11-24 |
Regents of the University of Minnesota |
Cd200ar ligands for cancer immunotherapy
|
|
US10889601B2
(en)
|
2019-02-11 |
2021-01-12 |
University Of Iowa Research Foundation |
Separations using boron containing hydrocarbon sponges
|
|
WO2020225779A1
(en)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Rig-i agonists for cancer treatment and immunotherapy
|
|
WO2020263989A1
(en)
|
2019-06-24 |
2020-12-30 |
University Of Iowa Research Foundation |
Jnk inhibitors as anticancer agents
|
|
US11840703B2
(en)
|
2019-07-01 |
2023-12-12 |
Matrexa LLC |
Recombinant versican isoforms and related compositions and methods
|
|
JOP20220021A1
(ar)
|
2019-08-06 |
2023-01-30 |
Biocryst Pharm Inc |
تخليق على مقياس العملية لمثبط كاليكرين في البلازما
|
|
US20230146256A1
(en)
|
2020-04-17 |
2023-05-11 |
Regents Of The University Of Minnesota |
SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF
|
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
|
WO2022155332A1
(en)
|
2021-01-13 |
2022-07-21 |
Blue Therapeutics, Inc. |
Methods of treating irritable bowel syndrome
|
|
JP2024508426A
(ja)
|
2021-02-22 |
2024-02-27 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
免疫調節物質及び免疫調節物質コンジュゲート
|
|
IL308171A
(en)
|
2021-05-04 |
2023-12-01 |
Univ Minnesota |
Contraceptive compounds and methods
|
|
WO2023081237A1
(en)
|
2021-11-03 |
2023-05-11 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
|
WO2023091689A1
(en)
|
2021-11-19 |
2023-05-25 |
University Of Iowa Research Foundation |
Combined use of mcr1-directed radiotherapy and immune checkpoint inhibition in the treatment of melanoma
|
|
WO2024006977A1
(en)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
|
WO2024009283A1
(en)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
At2 antagonists for non-addictive pain relief
|
|
TW202409024A
(zh)
|
2022-07-08 |
2024-03-01 |
美商愛克堤歐生物科學公司 |
治療性化合物及方法
|
|
WO2024102342A1
(en)
|
2022-11-10 |
2024-05-16 |
University Of Iowa Research Foundation |
Combination of a glutathione synthesis inhibitor such as buthionine sulphoximine and an immune checkpoint inhibitor, preferably pembrolizumab, to treat cancer, preferably drug-resistant melanoma
|
|
WO2024112932A1
(en)
|
2022-11-23 |
2024-05-30 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
WO2024124023A2
(en)
|
2022-12-07 |
2024-06-13 |
Rutgers, The State University Of New Jersey |
Carbonic anhydrase enzyme inhibitors and methods of use thereof
|
|
WO2024197165A1
(en)
|
2023-03-21 |
2024-09-26 |
University Of Iowa Research Foundation |
Broad spectrum antifungal keto-alkyl-pyridinium compounds
|
|
WO2024206284A2
(en)
|
2023-03-27 |
2024-10-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|